Efficacy of a Recombinant Genotype VII Vaccine against Challenge with Velogenic Newcastle Disease Virus
Journal of Vaccines and Immunology Research Article Background: Newcastle disease virus (NDV) genotype VII has become the dominant genotype in China. However, NDV genotype II was used to make current commercial NDV vaccines. The mismatch of genotypes between circulating and vaccine strains of viruses may compromise the efficacy of vaccines. #scholarlyfreearticles #scholarlyopenaccess #scholarlyjournals http://www.peertechz.com/Vaccines-Immunology/pdf/JVI-2-116.pdf